KYNB - FIBROGEN INC
7.14
0.129 1.807%
Share volume: 10,107
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$7.01
0.13
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-06-2024 | 11-12-2024 | 03-17-2025 | 05-12-2025 | 08-11-2025 | 11-10-2025 | 03-16-2026 | |
| Assets | |||||||||
| Total Assets | 365.868 M | 293.203 M | 264.421 M | 214.525 M | 165.213 M | 178.055 M | 137.014 M | 119.594 M | |
| Current Assets | 278.167 M | 209.459 M | 244.529 M | 196.509 M | 148.529 M | 162.322 M | 133.423 M | 99.073 M | |
| Inventories | 27.335 M | 25.397 M | 23.937 M | 3.155 M | 3.155 M | 3.863 M | 3.864 M | 3.743 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 71.865 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 41.106 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 105.734 M | 140.714 M | 131.003 M | 50.482 M | 33.609 M | 23.367 M | 117.975 M | 47.872 M | |
| Total Non-current Assets | 5.776 M | 6.912 M | 5.806 M | 0.000 | 0.000 | 0.000 | 3.035 M | 20.160 M | |
| Property Plant Equipment | 12.166 M | 10.917 M | 7.603 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 75.535 M | 72.827 M | 12.289 M | 18.016 M | 16.684 M | 15.733 M | 3.591 M | 20.521 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 365.868 M | 293.203 M | 264.421 M | 214.525 M | 165.213 M | 178.055 M | 137.014 M | 119.594 M | |
| Total liabilities | 552.023 M | 483.576 M | 466.121 M | 398.160 M | 340.142 M | 359.085 M | 119.529 M | 115.119 M | |
| Total current liabilities | 196.733 M | 148.589 M | 190.530 M | 133.306 M | 73.390 M | 155.895 M | 35.973 M | 29.242 M | |
| Accounts Payable | 4.353 M | 9.938 M | 9.238 M | 5.064 M | 7.282 M | 10.477 M | 5.093 M | 3.745 M | |
| Other liabilities | 135.959 M | 131.317 M | 76.593 M | 76.698 M | 77.797 M | 80.810 M | 82.983 M | 85.622 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 72.213 M | 72.478 M | 72.779 M | 73.092 M | 73.419 M | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 135.959 M | 131.317 M | 76.593 M | 76.698 M | 77.797 M | 80.810 M | 82.983 M | 85.622 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -228.122 M | -232.340 M | -243.667 M | -225.602 M | -216.896 M | -222.997 M | -17.028 M | -30.038 M | |
| Common stock | 1.653 B | 1.662 B | 1.669 B | 1.670 B | 1.672 B | 1.674 B | 1.677 B | 1.678 B | |
| Retained earnings | -1.875 B | -1.890 B | -1.907 B | -1.889 B | -1.885 B | -1.892 B | -1.692 B | -1.706 B |